- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Anastrozole Fulvestrant
Total 716 results
-
Karolinska InstitutetGöteborg UniversityWithdrawnInsulin Resistance | Kidney Failure, Chronic | End-Stage Renal Disease | HyperphosphatemiaSweden
-
Prof. Wolfgang JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHActive, not recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingMetastatic Breast Cancer | Advanced Malignancies | Recurrent Breast CancerChina
-
Treadwell Therapeutics, IncRecruitingBreast Cancer | Advanced Solid TumorUnited States
-
iOMEDICO AGNovartis PharmaceuticalsCompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast CancerGermany
-
Ottawa Hospital Research InstituteCanadian Breast Cancer FoundationCompleted
-
ExelixisTerminatedTriple Negative Breast Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States
-
Cancer Institute and Hospital, Chinese Academy...UnknownHormone Receptor Positive Advanced Breast CancerChina
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerChina, United States, Belgium, Germany, Italy, Austria, Japan, Australia, Canada, Sweden, Switzerland, United Kingdom, Spain, Denmark, France, Ireland, Israel, Netherlands, Korea, Republic of, Norway
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Recruiting
-
Guangdong Women and Children HospitalNot yet recruiting
-
Menarini GroupCompletedAdvanced or Metastatic Breast CancerSpain, Belgium, United Kingdom, France, United States, Italy
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Mara ChambersNovartisCompleted
-
Genzyme, a Sanofi CompanyCompletedNon-Hodgkin's Lymphoma | Autologous Transplantation
-
University of Maryland, BaltimoreRecruitingBreast CancerUnited States
-
AstraZenecaCompletedMcCune-Albright SyndromeFrance, Italy, United Kingdom, Germany
-
Federal University of São PauloCompleted
-
Spanish Breast Cancer Research GroupPfizerCompleted
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Isfahan University of Medical SciencesUnknownCongestive Heart FailureIran, Islamic Republic of
-
Dr. Reddy's Laboratories LimitedCompleted
-
Borstkanker Onderzoek GroepNovartis Pharma B.V.; BOOG Study CenterRecruitingNeoplasm, Breast | Congenital, Familial and Genetic DisordersNetherlands
-
Centre Leon BerardActive, not recruitingEndometrial Carcinoma | Hormone Receptor Positive Tumor | Metastatic CarcinomaFrance
-
Hospital Universitari Vall d'Hebron Research InstituteVitae Health InnovationCompletedChronic Fatigue SyndromeSpain
-
Joyce Marie SlingerlandStanford UniversityCompleted
-
Roswell Park Cancer InstituteAstraZeneca; National Center for Complementary and Integrative Health (NCCIH)Completed
-
Stanford UniversityAstraZenecaTerminated
-
Institute of Cancer Research, United KingdomActive, not recruitingBreast CancerUnited Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedNasal PolypsSpain, Belgium, United States, Sweden
-
National Taiwan University HospitalRecruitingMetastatic Breast Cancer | Premenopausal Breast Cancer | ER Positive Breast CancerTaiwan
-
Institut CurieRain Oncology IncTerminatedAdvanced or Metastatic Breast CancerFrance
-
Genentech, Inc.CompletedBreast CancerBelgium, Israel, United States, Spain, Denmark, Germany, Hong Kong, Russian Federation, Australia, New Zealand, Korea, Republic of, Malaysia, Singapore, Italy, Czech Republic, France, Peru, Canada, United Kingdom, Chile, Thailand, Argentin... and more
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownRecurrent Uterine Corpus Carcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7
-
Eli Lilly and CompanyActive, not recruitingBreast CancerCanada, Germany, Australia, Japan, United States, Taiwan, Belgium, New Zealand, Italy, Israel, Spain, France, Netherlands, Mexico, Turkey, United Kingdom, Korea, Republic of, Austria, Puerto Rico, Sweden, Russian Federation, Greece, Slovaki...
-
MedSIRCellestia Biotech AGTerminated
-
Stanford UniversityCompleted
-
University of PennsylvaniaJohns Hopkins University; University of Colorado, Denver; Washington University... and other collaboratorsCompletedPulmonary Arterial HypertensionUnited States
-
Maastricht University Medical CenterCompleted
-
Dr. Reddy's Laboratories LimitedCompleted
-
Korea University Anam HospitalKorea UniversityUnknownBreast Neoplasms | Arthritis | Arthralgia | Genetic PolymorphismKorea, Republic of
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina